Cargando…
Prognostic Significance of the Dynamic Change of Programmed Death-ligand 1 Expression in Patients with Multiple Myeloma
Background The inhibition of programmed cell death protein 1/programmed death-ligand 1 (PD-1/PD-L1) signaling pathway has been shown to be an effective targeted therapy in fighting both solid organ cancers and hematological malignancies. PD-L1 expression also serves as a prognostic marker in various...
Autores principales: | Guan, Jian, Wang, Renching, Hasan, Syed, Tao, Luwei, Wazir, Mohammed, Jain, Akriti G, Zhu, Xiang, Perkins, Sherrie, Mohamed, Salama, Chang, Chung-Che, Mori, Shahram |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6559697/ https://www.ncbi.nlm.nih.gov/pubmed/31245191 http://dx.doi.org/10.7759/cureus.4401 |
Ejemplares similares
-
Programmed Cell Death Protein 1 (PD-1) and Programmed Cell Death Ligand 1 (PD-L1) Immunotherapy: A Promising Breakthrough in Cancer Therapeutics
por: Abaza, Abdelrahman, et al.
Publicado: (2023) -
Common Sensitive Diagnostic and Prognostic Markers in Hepatocellular Carcinoma and Their Clinical Significance: A Review
por: Samman, Basim Saleh, et al.
Publicado: (2022) -
Serum Tumor Necrosis Factor-Alpha Levels in Acute Leukemia and Its Prognostic Significance
por: Verma, Sapana, et al.
Publicado: (2022) -
Standardization of Manual Method of Immunohistochemical Staining for Breast Cancer Biomarkers at Tertiary Cancer Care Center: An Audit
por: Rana, Manjit K, et al.
Publicado: (2022) -
Expression of p53 and p16 in Carcinoma Breast Tissue: Depicts Prognostic Significance or Coincidence
por: Rana, Manjit K, et al.
Publicado: (2021)